PMPaolo Monciardini

Paolo Monciardini

*This is an algorithmically generated author record based on publicly available information.

Paolo Monciardini has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Trends in metabolite discovery from Actinomycetes

    by Paolo Monciardini, Matteo Simone, Marianna Iorio, Sonia I. Maffioli, Margherita Sosio, Stefano Donadio

    Actinomycetes continue to provide new molecules at a steady rate. Here we analyze the contribution of four approaches to the discovery of new metabolites, and which strategies are more effective at yielding structurally original molecules.


  • The Molecules Gateway: A Homogeneous, Searchable Database of 150k Annotated Molecules from Actinomycetes

    by Matteo Simone, Marianna Iorio, Paolo Monciardini, Massimo Santini, Niccolò Cantù, Arianna Tocchetti, Stefania Serina, Cristina Brunati, Thomas Vernay, Andrea Gentile, et al.

    Natural products are a sustainable resource for drug discovery, but their identification in complex mixtures remains a daunting task. We present an automated pipeline that compares, harmonizes and ranks the annotations of LC-HRMS data by different tools. When applied to 7,400 extracts derived from 6,566 strains belonging to 86 actinomycete genera, it yielded 150,000 molecules after processing over 50 million MS features. The web-based Molecules Gateway provides a highly interactive access to experimental and calculated data for these molecules, along with the metadata related to extracts and producer strains. We show how the Molecules Gateway can be used to rapidly identify known hard to find microbial products, unreported analogs of known families and not yet described metabolites. The Molecules Gateway, which complements available repositories, contains annotated MS data, both acquired and computationally processed under an identical workflow, making it suitable for global analyses which reveal a large and untapped chemical diversity afforded by actinomycetes.


  • Open Access

    The Molecules Gateway: a homogeneous, searchable database of 150k annotated molecules from Actinomycetes

    by Matteo Simone, Marianna Iorio, Paolo Monciardini, Massimo Santini, Niccolò Cantù, Arianna Tocchetti, Stefania Serina, Cristina Brunati, Thomas Vernay, Andrea Gentile, et al.

    Natural products are a sustainable resource for drug discovery, but their identification in complex mixtures remains a daunting task. We present an automated pipeline that compares, harmonizes and ranks the annotations of LC-HRMS data by different tools. When applied to 7,400 extracts derived from 6,566 strains belonging to 86 actinomycete genera, it yielded 150,000 molecules after processing over 50 million MS features. The web-based Molecules Gateway provides a highly interactive access to experimental and calculated data for these molecules, along with the metadata related to extracts and producer strains. We show how the Molecules Gateway can be used to rapidly identify known hard to find microbial products, unreported analogs of known families and not yet described metabolites. The Molecules Gateway, which complements available repositories of annotated MS data, is experimentally and computationally homogeneous, and thus amenable to global analyses, which show a large and untapped chemical diversity afforded by actinomycetes.

  • Open Access

    Reticulibacter mediterranei gen. nov., sp. nov., within the new family Reticulibacteraceae fam. nov., and Ktedonospora formicarum gen. nov., sp. nov., Ktedonobacter robiniae sp. nov., Dictyobacter formicarum sp. nov. and Dictyobacter arantiisoli sp. nov., belonging to the class Ktedonobacteria

    by Shuhei Yabe, Yu Zheng, Chiung-Mei Wang, Yasuteru Sakai, Keietsu Abe, Akira Yokota, Stefano Donadio, Linda Cavaletti, Paolo Monciardini

    The aerobic, Gram-positive, mesophilic Ktedonobacteria strains, Uno17T, SOSP1-1T, 1-9T, 1-30T and 150040T, formed mycelia of irregularly branched filaments, produced spores or sporangia, and numerous secondary metabolite biosynthetic gene clusters. The five strains grew at 15–40 °C (optimally at 30 °C) and pH 4.0–8.0 (optimally at pH 6.0–7.0), and had 7.21–12.67 Mb genomes with 49.7–53.7 mol% G+C content. They shared MK9(H2) as the major menaquinone and C16 : 1-2OH and iso-C17 : 0 as the major cellular fatty acids. Phylogenetic and phylogenomic analyses showed that Uno17T and SOSP1-9T were most closely related to members of the genus Dictyobacter , with 94.43–96.21 % 16S rRNA gene similarities and 72.16–81.56% genomic average nucleotide identity. The strain most closely related to SOSP1-1T and SOSP1-30T was Ktedonobacter racemifer SOSP1-21T, with 91.33 and 98.84 % 16S rRNA similarities, and 75.13 and 92.35% average nucleotide identities, respectively. Strain 150040T formed a distinct clade within the order Ktedonobacterales , showing <90.47 % 16S rRNA gene similarity to known species in this order. Based on these results, we propose: strain 150040T as Reticulibacter mediterranei gen. nov., sp. nov. (type strain 150 040T=CGMCC 1.17052T=BCRC 81202T) within the family Reticulibacteraceae fam. nov. in the order Ktedonobacterales ; strain SOSP1-1T as Ktedonospora formicarum gen. nov., sp. nov. (type strain SOSP1-1T=CGMCC 1.17205T=BCRC 81203T) and strain SOSP1-30T as Ktedonobacter robiniae sp. nov. (type strain SOSP1-30T=CGMCC 1.17733T=BCRC 81205T) within the family Ktedonobacteraceae ; strain Uno17T as Dictyobacter arantiisoli sp. nov. (type strain Uno17T=NBRC 113155T=BCRC 81116T); and strain SOSP1-9T as Dictyobacter formicarum sp. nov. (type strain SOSP1-9T=CGMCC 1.17206T=BCRC 81204T) within the family Dictyobacteraceae .


  • Ktedonobacteraceae

    by Paolo Monciardini, Linda Cavaletti, Stefano Donadio

    Kte.do.no.bac.ter.a.ce'ae. N.L. masc. n. Ktedonobacter , type genus of the family, suff. ‐ aceae ending to denote a family; N.L. fem. pl. n. Ktedonobacteraceae , the Ktedonobacter family. Members of the family Ktedonobacteraceae are characterized by non‐fragmenting vegetative mycelium, aerial hyphae are produced. Single spherical and nonmotile spores are formed on the aerial mycelium, individual spores can be associated in clusters. Gram‐positive, non‐acid‐fast. Strains grow as mesophilic heterotrophs in aerobic conditions. Starch and casein are hydrolyzed. Growth occurs in presence of NaCl up to 2%. Optimal temperature for growth is 28–33°C, and optimal pH is 6. Catalase positive. The major cell‐wall sugars are mannose, xylose, and glucose. They contain d ‐glutamic acid, glycine, l ‐serine, l ‐alanine, d ‐alanine, β‐alanine, and l ‐ornithine as peptidoglycan amino acids. The major menaquinone is MK‐9 (H 2 ). Major fatty acids are C 16:1 2OH and iso‐C 17:0 . Phosphatidylglycerol, diphosphatidylglycerol, and phosphatidylinositol are present in the polar lipid pattern. The family currently comprises only the type genus Ktedonobacter . Members of the family were isolated from soil. DNA G + C content (mol%) : 54–56. Type genus : Ktedonobacter Cavaletti et al. 2007 (Effective publication: Cavaletti et al. 2006). Taxonomic and Nomenclature Notes: According to the List of Prokaryotic names with Standing in Nomenclature (LPSN), the taxonomic status of the family Ktedonobacteraceae is: correct name (last update, February 2025) * . LPSN classification: Bacteria / Bacillati / Chloroflexota / Ktedonobacteria / Ktedonobacterales / Ktedonobacteraceae The family Ktedonobacteraceae can also be recovered in the Genome Taxonomy Database (GTDB) as f__Ktedonobacteraceae (version v220) ** . GTDB classification: d__Bacteria / p__Chloroflexota / c__Ktedonobacteria / o__Ktedonobacterales / f__Ktedonobacteraceae * Meier‐Kolthoff et al. ( 2022 ). Nucleic Acids Res , 50 , D801 – D807 ; DOI: 10.1093/nar/gkab902 ** Parks et al. ( 2022 ). Nucleic Acids Res , 50 , D785 – D794 ; DOI: 10.1093/nar/gkab776

  • Open Access

    Antibacterial Aromatic Polyketides Incorporating the Unusual Amino Acid Enduracididine

    by Paolo Monciardini, Alice Bernasconi, Marianna Iorio, Cristina Brunati, Margherita Sosio, Laura Campochiaro, Paolo Landini, Sonia I. Maffioli, Stefano Donadio

    The increasing incidence of infections caused by drug-resistant pathogens requires new efforts for the discovery of novel antibiotics. By screening microbial extracts in an assay aimed at identifying compounds interfering with cell wall biosynthesis, based on differential activity against a Staphylococcus aureus strain and its isogenic l-form, the potent enduracyclinones (1, 2), containing the uncommon amino acid enduracididine linked to a six-ring aromatic skeleton, were discovered from different Nonomuraea strains. The structures of 1 and 2 were established through a combination of derivatizations, oxidative cleavages, and NMR analyses of natural and 13C–15N-labeled compounds. Analysis of the biosynthetic cluster provides the combination of genes for the synthesis of enduracididine and type II polyketide synthases. Enduracyclinones are active against Gram-positive pathogens (especially Staphylococcus spp.), including multi-drug-resistant strains, with minimal inhibitory concentrations in the range of 0.0005 to 4 μg mL–1 and with limited toxicity toward eukaryotic cells. The combined results from assays and macromolecular syntheses suggest a possible dual mechanism of action in which both peptidoglycan and DNA syntheses are inhibited by these molecules.


  • Open Access

    Antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase: pseudouridimycin

    by Sonia I. Maffioli, Yu Zhang, David Degen, Thomas Carzaniga, Giancarlo Del Gatto, Stefania Serina, Paolo Monciardini, Carlo Mazzetti, Paola Guglierame, Gianpaolo Candiani, et al.

    There is an urgent need for new antibacterial drugs effective against bacterial pathogens resistant to current drugs 1–2 . Nucleoside-analog inhibitors (NAIs) of viral nucleotide polymerases have had transformative impact in treatment of HIV 3 and HCV 4 . NAIs of bacterial RNA polymerase (RNAP) potentially could have major impact on treatment of bacterial infection, particularly because functional constraints on substitution of RNAP nucleoside triphosphate (NTP) binding sites 4-5 could limit resistance emergence 4-5 . Here we report the discovery, from microbial extract screening, of an NAI that inhibits bacterial RNAP and exhibits antibacterial activity against a broad spectrum of drug-sensitive and drug-resistant bacterial pathogens: pseudouridimycin (PUM). PUM is a novel microbial natural product consisting of a formamidinylated, N-hydroxylated Gly-Gln dipeptide conjugated to 6'-amino-pseudouridine. PUM potently and selectively inhibits bacterial RNAP in vitro, potently and selectively inhibits bacterial growth in culture, and potently clears infection in a mouse model of Streptococcus pyogenes peritonitis. PUM inhibits RNAP through a binding site on RNAP (the "i+1" NTP binding site) and mechanism (competition with UTP for occupancy of the "i+1" NTP binding site) that differ from those of the RNAP inhibitor and current antibacterial drug rifampin (Rif). PUM exhibits additive antibacterial activity when co-administered with Rif, exhibits no cross-resistance with Rif, and exhibits a spontaneous resistance rate an order-of-magnitude lower than that of Rif. The results provide the first example of a selective NAI of bacterial RNAP, provide an advanced lead compound for antibacterial drug development, and provide structural information and synthetic routes that enable lead optimization for antibacterial drug development.


  • Open Access

    Inorganic phosphate is a trigger factor for Microbispora sp. ATCC-PTA-5024 growth and NAI-107 production

    by Anna Giardina, Rosa Alduina, Giuseppe Gallo, Paolo Monciardini, Margherita Sosio, Anna Maria Puglia

    NAI-107, produced by the actinomycete Microbispora sp. ATCC-PTA-5024, is a promising lantibiotic active against Gram-positive bacteria and currently in late preclinical-phase. Lantibiotics (lanthionine-containing antibiotics) are ribosomally synthesized and post-translationally modified peptides (RiPPs), encoded by structural genes as precursor peptides. The biosynthesis of biologically active compounds is developmentally controlled and it depends upon a variety of environmental stimuli and conditions. Inorganic phosphate (Pi) usually negatively regulates biologically-active molecule production in Actinomycetes, while it has been reported to have a positive control on lantibiotic production in Firmicutes strains. So far, no information is available concerning the Pi effect on lantibiotic biosynthesis in Actinomycetes. After having developed a suitable defined medium, Pi-limiting conditions were established and confirmed by quantitative analysis of polyphosphate accumulation and of expression of selected Pho regulon genes, involved in the Pi-limitation stress response. Then, the effect of Pi on Microbispora growth and NAI-107 biosynthesis was investigated in a defined medium containing increasing Pi amounts. Altogether, our analyses revealed that phosphate is necessary for growth and positively influences both growth and NAI-107 production up to a concentration of 5 mM. Higher Pi concentrations were not found to further stimulate Microbispora growth and NAI-107 production. These results, on one hand, enlarge the knowledge on Microbispora physiology, and, on the other one, could be helpful to develop a robust and economically feasible production process of NAI-107 as a drug for human use.


  • Chapter 7. New Lantibiotics from Natural and Engineered Strains

    by Sonia I. Maffioli, Paolo Monciardini, Margherita Sosio, Stefano Donadio

    During the last three decades, the incidence of drug resistance among major bacterial pathogens has greatly outpaced the number of new antibacterial agents introduced into clinical practice, leading to the so-called ‘antibiotic crisis’, which has been exacerbated by the approval of just two new chem...